Rachel Hellemans
Overview
Explore the profile of Rachel Hellemans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boerstra B, Pippias M, Kramer A, Dirix M, Daams J, Jager K, et al.
Clin Kidney J
. 2025 Feb;
18(1):sfae377.
PMID: 40008352
Before patients with kidney failure can undergo kidney transplantation, their suitability is assessed through a transplantation work-up. Variation in the transplantation work-up could contribute to inefficiency and inequality in accessing...
2.
Laghrib Y, Hilbrands L, Oniscu G, Crespo M, Gandolfini I, Mariat C, et al.
Clin Kidney J
. 2025 Jan;
18(1):sfae367.
PMID: 39839808
Background: Although post-transplant diabetes mellitus (PTDM) is a common complication after kidney transplantation, there are few data on prevention, optimal screening, and treatment strategies. Methods: The European Renal Association's DESCARTES...
3.
Kramer A, Boenink R, Mercado Vergara C, Bell S, Kerschbaum J, Arevalo O, et al.
Nephrol Dial Transplant
. 2024 May;
39(12):2100-2112.
PMID: 38724446
Background: Preemptive kidney transplantation (PEKT) has better outcomes when compared with transplantation after dialysis. We aimed to examine trends in PEKT between 2000 and 2019 in Europe and to provide...
4.
Ernst A, Regele H, Chatzikyrkou C, Dendooven A, Turkevi-Nagy S, Tieken I, et al.
Nephrol Dial Transplant
. 2024 Apr;
40(1):83-108.
PMID: 38632055
Background: The decision to accept or discard the increasingly rare and marginal brain-dead donor kidneys in Eurotransplant (ET) countries has to be made without solid evidence. Thus, we developed and...
5.
Perez-Saez M, Montero N, Oliveras L, Redondo-Pachon D, Martinez-Simon D, Abramovicz D, et al.
Transplant Rev (Orlando)
. 2023 Sep;
37(4):100787.
PMID: 37657355
Background: Kidney transplant (KT) recipients of HLA identical siblings (HLAid) have lower immunological risk, but there are no specific recommendations for immunosuppression. Our aim was to analyze evidence about results...
6.
Laghrib Y, Massart A, de Fijter J, Abramowicz D, De Block C, Hellemans R
J Nephrol
. 2023 Apr;
36(7):1921-1929.
PMID: 37039964
Background: Post-transplant diabetes mellitus occurs in 10-40% of kidney transplant recipients and is associated with increased risk of developing cardiovascular diseases. Early identification of patients with a higher risk of...
7.
Haverals L, Roosens L, Wouters K, Marquet P, Monchaud C, Massart A, et al.
Transplant Direct
. 2023 Apr;
9(4):e1439.
PMID: 37009168
Methods: We retrospectively analyzed data from 53 patients in which a 24-h Tac AUC estimation was performed at our center. Patients were divided into those taking a low (≤0.15 mg/kg)...
8.
Deleersnijder D, Laurens W, De Meester J, Cleenders E, Dendooven A, Lerut E, et al.
Clin Kidney J
. 2023 Feb;
16(1):125-137.
PMID: 36726429
Background: The Flemish Collaborative Glomerulonephritis Group (FCGG) registry provides complete population data on kidney disease epidemiology in the region of Flanders (Belgium), as it captures all native kidney biopsies performed...
9.
Grossi A, Sever M, Hellemans R, Mariat C, Crespo M, Watschinger B, et al.
Nephrol Dial Transplant
. 2023 Jan;
38(7):1613-1622.
PMID: 36702535
Living donation challenges the ethical principle of non-maleficence in that it exposes healthy persons to risks for the benefit of someone else. This makes safety, informed consent (IC) and education...
10.
Hellemans R, Bertels A, Wijtvliet V, Wouters K, Massart A, Bergs K, et al.
Transplant Proc
. 2023 Jan;
55(1):123-128.
PMID: 36609024
Background: BK polyomavirus-associated nephropathy (PVAN) is a frequent complication in the early phase after kidney transplantation. The most important risk factor for PVAN is the intensity of immunosuppression. A recent...